1,036 results on '"Frölich, Lutz"'
Search Results
2. Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
3. Differential Psychological Treatment Effects in Patients With Late-Life Depression and a History of Childhood Maltreatment
4. Reduced tactile sensitivity is associated with mild cognitive impairment
5. Effects of an app-based sensorimotor training in promoting neuroplasticity and neuropsychological functioning in frailty: A randomized controlled trial
6. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
7. Lecanemab: Appropriate Use Recommendations — A Commentary from a European Perspective
8. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
9. Sodium signal intensity of CSF using 1H‐guided 23Na‐MRI as a potential noninvasive biomarker in Alzheimer's disease
10. Longitudinal automated brain volumetry vs. expert visual assessment of atrophy progression on MRI is robust but caution is advised
11. Perceived Physical Health and Cognitive Behavioral Therapy vs Supportive Psychotherapy Outcomes in Adults With Late-Life Depression
12. Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
13. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
14. Sensory and motor correlates of frailty: dissociation between frailty phenotype and frailty index
15. Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit
16. Alzheimer's disease – the ‘microbial hypothesis’ from a clinical and neuroimaging perspective
17. Spezielle Aspekte bezogen auf Organsysteme nach geriatrisch-klinischer Bedeutung
18. Molecular analysis of nasal secretion to identify Alzheimer’s disease
19. Early Detection of Alzheimer’s Disease using microRNAs
20. Promoting neuroplasticity and neuropsychological functioning in frailty through an app-based sensorimotor training: study protocol for a randomized trial
21. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
22. Erratum zu: Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
23. Erratum zu: Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit
24. Nicht invasive Hirnstimulation
25. Inflammatory biomarkers in Alzheimer's disease plasma
26. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
27. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
28. Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
29. Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
30. Blood-based multivariate methylation risk score for cognitive impairment and dementia
31. A Confirmatory and an Exploratory Factor Analysis of the Cohen-Mansfield Agitation Inventory (CMAI) in a European Case Series of Patients with Dementia: Results from the RECage Study
32. Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
33. Tactile sensitivity is reduced in mild cognitive impairment
34. Effects of an app-based sensorimotor training in promoting neuroplasticity and neuropsychological functioning in frailty: a randomized controlled trial
35. Effects of sensorimotor training on memory and brain plasticity in persons with amnestic mild cognitive impairment
36. BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study
37. Spezielle Aspekte bezogen auf Organsysteme nach geriatrisch-klinischer Bedeutung
38. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
39. The European DTI Study on Dementia — A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment
40. Consensus guidelines for lumbar puncture in patients with neurological diseases
41. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
42. Autorinnen und Autoren
43. Electroconvulsive therapy selectively enhances amyloid β 1–42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study
44. Spezielle Aspekte bezogen auf Organsysteme nach geriatrisch klinischer Bedeutung
45. Apathy in patients with Alzheimer's disease is a cost‐driving factor
46. Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial
47. Whole‐exome rare‐variant analysis of Alzheimer's disease and related biomarker traits
48. Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
49. 6 .Diagnostische Methoden
50. Autorinnen und Autoren
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.